Home/Pipeline/Maraviroc Tablets

Maraviroc Tablets

HIV Infection

ApprovedActive

Key Facts

Indication

HIV Infection

Phase

Approved

Status

Active

Company

i3 Pharmaceuticals

About i3 Pharmaceuticals

i3 Pharmaceuticals is a specialty generic drug company founded by industry veterans to address high-barrier, complex solid oral dosage forms. The company's strategy centers on applying deep technical know-how to develop and manufacture generics for poorly soluble, unstable, or potent compounds, with a fully integrated US-based facility for development through commercial supply. Since its operational launch, i3 has successfully passed FDA inspections and commercialized several products, positioning itself in the niche but valuable market for technically challenging generics.

View full company profile

Therapeutic Areas

Infectious Disease Cardiology Central Nervous System Other Specialty

Other HIV Infection Drugs

Drug	Company	Phase	Status
HIV Self Test	Atomo Diagnostics	Commercial	Active
HIV Treatment Portfolio	MSD	Commercial	Active
IML-106	Immunologik	Pre-clinical	Active
HIV Antibodies	Polymun Scientific	Pre-clinical	Active
HIV Program	Vichem Chemie Research	Pre-clinical	Active
Abacavir	Laboratorio Elea Phoenix	Commercial	Active